Division of Carbohydrate Chemistry--Inosine Monophosphate Dehydrogenase: Perspectives on a Major Therapeutic Target
Witczak, Z.J.
Idrugs the Investigational Drugs Journal 3(11): 1283-1284
2000
ISSN/ISBN: 1369-7056 PMID: 16047237 Document Number: 515437
Document emailed within 1 workday
Related Documents
H.-Seelig, P.; Appelhans, H.; Bauer, O.; Bl, M.üthner; Hartung, K.; Schranz, P.; Schultze, D.; Seelig, C.A.; Volkmann, M. 2011: Autoantibodies Against Inosine-5’-Monophosphate Dehydrogenase 2 – Characteristics and Prevalence in Patients with HCV-Infection Clinical Laboratory 57(9-10): 753-765Agathangelou, P. 1999: Division of Carbohydrate Chemistry--recent developments in oligonucleotide therapeutics Idrugs: the Investigational Drugs Journal 2(6): 519-520
Tugaĭ, V.A.; Akulin, V.N.; Epshteĭn, L.M. 1987: Isolation of inosine-5'-monophosphate from fish muscles Ukrainskii Biokhimicheskii Zhurnal 59(3): 56-60
Vasilevskaia, L.S.; Rymshina, M.V.; Shlygin, G.K. 1993: Effect of glutamate and combined with inosine monophosphate on gastric secretion Voprosy Pitaniia 3: 29-33
Czarnecki, W. 1982: Inosine. II. Perspectives of its use in cardiological diagnosis and therapy Kardiologia Polska 25(7-8): 639-645
Agathangelou, P. 1999: Division of Medicinal Chemistry--endothelins Idrugs: the Investigational Drugs Journal 2(6): 515-516
Sokoloski, J.A.; Blair, O.C.; Sartorelli, A.C. 1986: Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase Cancer Research 46(5): 2314-2319
Miyahara, M.; Kamiya, S.; Nakadate, M.; Sueyoshi, S.; Tanno, M.; Miyahara, M.; Maekawa, A.; Odashima, S. 1979: Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry. (III) Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 1979(97): 107-109
Miyahara, M.; Kamiya, S.; Nakadate, M.; Sueyoshi, S.; Tanno, M.; Miyahara, M.; Suzuki, I.; Odashima, S. 1978: Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry. (II) Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 1978(96): 91-94
Thomas, S. 2000: Division of Medicinal Chemistry--second poster session and general papers Idrugs: the Investigational Drugs Journal 3(6): 569-570
Miyahara, M.; Kamiya, S.; Nakadate, M.; Sueyoshi, S.; Tanno, M.; Miyahara, M.; Maekawa, A.; Odashima, S. 1980: Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (IV) Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 98: 123-125
Barnes, B.J.; Izydore, R.A.; Eakin, A.E.; Hall, I.H. 2001: Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type Ii inosine 5'-monophasphate dehydrogenase Journal of Pharmacology and Experimental Therapeutics 298(2): 790-796
Avantaggiati, M.L. 2013: Cancer metabolism as a therapeutic target: finding the right target(s) in the context of tumor heterogeneity, evolution, and metabolic plasticity Oncology 27(5): 474; 476-477
Collart, F.R.; Chubb, C.B.; Mirkin, B.L.; Huberman, E. 1992: Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines Cancer Research 52(20): 5826-5828
Rotella, D. 2001: 221st ACS. Division of Medicinal Chemistry - inhibitors of HIV entry: potential new therapies for treatment of HIV infection Idrugs: the Investigational Drugs Journal 4(6): 629-630
Tricot, G.; Weber, G. 1996: Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity Anticancer Research 16(6a): 3341-3347
Recanatini, M. 1996: Receptors and medicinal chemistry: new methods and perspectives Farmaco 51(1): 5-12
Jordan, V.C.; Dix, C.J.; Prestwich, G. 1979: Inhibition of cell division and stimulation of progesterone receptor synthesis in rat oestrogen target tissues by non-steroidal antioestrogens Advances in Experimental Medicine and Biology 117: 133-155
Dybkaer, R. 1979: International Union of Pure and Applied Chemistry and International Federation of Clinical Chemistry. IUPAC Section on Clinical Chemistry Commission on Quantities and Units in Clinical Chemistry and IFCC Committee on Standards Expert Panel on Quantities and Units approved recommendation (1978). List of quantities in clinical chemistry Journal of Clinical Chemistry and Clinical Biochemistry 17(12): 822-835
Lehmann, H.P.; Worth, H.G.; Zinder, O. 1990: International Federation of Clinical Chemistry. Education Division. Expert Panel on Quantities and Units. A protocol for the conversion of clinical laboratory data Annales de Biologie Clinique 48(1): 44-47